Loading…
Clemex Technologies entered into a merger agreement with a purchaser owned by principal shareholders (including RAL Diagnostics, Zwick Roell AG, and CEO Yves Bassat) to acquire all outstanding shares for $0.20 per share, totaling about $3.8 million.